Caas Capital Management LP Fusion Pharmaceuticals Inc. Transaction History

Caas Capital Management LP

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2021 May 17, 2021	SELL	$9.75 - $13.09 $225,693 - $303,007	-23,148 Closed	0 $0
Q4 2020 Feb 12, 2021	SELL	$11.5 - $13.73 $405,375 - $483,982	-35,250 Reduced 60.36%	23,148 $272,000
Q3 2020 Nov 09, 2020	SELL	$11.8 - $17.1 $18,903 - $27,394	-1,602 Reduced 2.67%	58,398 $702,000
Q2 2020 Aug 14, 2020	BUY	$17.0 - $17.78 $1.02 Million - $1.07 Million	60,000 New	60,000 $1.05 Million

93K

1.4K

Ticker FUSN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 43,390,500
Description
Fusion Pharmaceuticals Inc., a clinical-stage oncology company, focuses on developing radiopharmaceuticals as precision medicines. The company has developed Targeted Alpha Therapies platform together with its proprietary Fast-Clear linker technology to enable us to connect alpha particle emitting isotopes to various targeting molecules in order ...

Get notified when there are updates to the investment portfolio of Caas Capital Management LP, based on Form 13F filings with the SEC.

Stay updated on Caas Capital Management LP with notifications on news.